NIPT
Devyser Fetal RHD Screening Test Receives IVDR Certification
The qPCR-based test can help determine the rhesus D antigen status of the fetus in a pregnant woman.
Devyser Fetal Abnormality Test Nabs China Approval; Firm, Thermo Fisher Collaborate on FDA Approval
The fetal abnormality test measures the most common chromosomal abnormalities, including Down syndrome, via a single-tube PCR process.
Natera Reports 52 Percent Spike in Q1 Revenues, Raises Full-Year Guidance
The company beat analysts' estimates on the top and bottom lines with growth driven by increased testing volumes and improvements in average test selling price.
Early IDENTIFY Trial Results Suggest Half of Women With Non-Reportable NIPT Result Have Cancer
At the American College of Medical Genetics and Genomics annual meeting, NICHD Director Diana Bianchi reported that whole-body MRI was the best follow-up test to confirm or rule out cancer.
Jury Awards Natera $96.2M in Damages in Patent Infringement Case Against CareDx
A jury awarded Natera $12.6 million in past royalties and $83.7 million for lost profits related to patents covering Natera's Panorama technology.
Dec 22, 2023
Wells Fargo Initiates Coverage of Revvity
Jul 31, 2023
Juno Diagnostics Ceases Commercial Operations
Apr 19, 2023
Ravgen Prevails Over Streck in Patent Challenge
Apr 17, 2023
Illumina, Ravgen Settle Patent Lawsuit Over NIPTs
Jan 25, 2023
Ravgen NIPT Patents Withstand Illumina Challenge
Dec 6, 2022
Cowen Upgrades PerkinElmer Stock to Outperform
Oct 20, 2022